Driving breakthroughs in cancer research

Accurate next-generation sequencing methods for a comprehensive view of cancer-causing mutations

Cancer Sequencing Methods

Cancer sequencing using next-generation sequencing (NGS) methods provides more information in less time compared to traditional single-gene and array-based approaches. With NGS, researchers can perform whole-genome studies, targeted gene profiling, tumor-normal comparisons, and more. NGS also offers the sensitivity to detect rare somatic variants, tumor subclones, and circulating DNA fragments.

Oncology
Cancer Whole-Genome Sequencing

See a comprehensive view of the unique mutations present in tumor tissue.

Learn More
Cancer Exome Sequencing

Cost-effectively identify coding variants related to tumor progression.

Learn More
Targeted Cancer Sequencing

Focus on a set of genes with known cancer associations.

Learn More
Cancer RNA Sequencing

RNA sequencing can help determine which variants are expressed and affect tumor cell function.

Learn More
Noninvasive Cancer Biomarkers

Use the high sensitivity of NGS to detect noninvasive biomarkers, such as circulating tumor DNA.

Learn More
Image
High-Throughput Genomics Technologies for Cancer Research

Learn how NGS-based cancer sequencing can provide a deeper understanding of tumor biology.

Access PDF
Image
Sequencing FFPE DNA

Read how Dr. Yasser Riazalhosseini preserves the integrity of degraded FFPE DNA for sequencing.

Access PDF
Interested in receiving newsletters, case studies, and information on cancer genomics?
Sign Up
Image
Detection of Actionable Alterations in Tumors

Wagle et al. demonstrate detection of genomic alterations in tumor samples by high-throughput sequencing.

Read Paper
Image
Cancer Research Review

An overview of recent cancer research publications featuring Illumina technology.

Access PDF
Image
Cancer and Immune System Research Review

An overview of recent research publications exploring the interaction between tumor cells and the immune system.

Access PDF
Image
Sequencing Limited or Low-Quality Tumor Samples

Find solutions that facilitate analysis of FFPE and limited (needle biopsy or aspirate) tumor DNA.

Learn More